Background: Human cytomegalovirus(HCMV)isthemostcommonopportunisticvirusinfectioninsolid organ transplantrecipients.TheanalysisofHCMV-specificT-cellimmunityafterorgantransplantisof relevant clinicalinterest. Objectives: To analyzeHCMV-specificCD4+ and CD8+ T-cell responsesinhealthysubjectsandkidney transplant recipients(KTR). Study design: HCMV-specific T-cellresponseswereevaluatedbyinterferon- (IFN-) enzyme-linked immunospot (ELISPOT)usingoverlapping15-merpeptidepoolsofimmediateearly(IE)-1,IE-2,phos- phoprotein 65(pp65)(forstimulationofbothCD4+ and CD8+ T-cell responses)andapoolof34short peptides (8–12aminoacidsinlength,forstimulationofCD8+ T-cell responses).ELISPOTresultswere normalized toT-cellsubsetcountsandtheircorrelationswithareporteddendriticcell(DC)-basedassay, which simultaneouslyquantifiesHCMV-specificCD4+ and CD8+ T-cell responses,wereanalyzed. Results: HCMV-seropositive KTRshowedhigherELISPOTresponsescomparedtoHCMV-seropositive healthy subjects.IE-1andpp65ELISPOTresponsesweremediatedmainlybyCD8+ T-cells and,toa lesser extent,CD4+ T cells;IE-2peptidesappeartostimulateCD56+ cells (naturalkillercells).InHCMV- seropositive healthysubjects,ELISPOTresults(expressedeitherasnetspots/millioncellsornormalized to thecorrespondingT-cellcount)significantlycorrelatedwiththeDCassay.However,inHMCV- seropositive KTR,onlynormalizedELISPOTresponsestooverlapping15-merpeptidepoolssignificantly correlated withDC-assayresponses. Conclusions: The normalizedELISPOTrepresentsanovelandsimpleapproachforquantifyingandmoni- toring HCMV-specificCD4+ and CD8+ T-cell responsesinKTR
Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients
Esposito P;
2014-01-01
Abstract
Background: Human cytomegalovirus(HCMV)isthemostcommonopportunisticvirusinfectioninsolid organ transplantrecipients.TheanalysisofHCMV-specificT-cellimmunityafterorgantransplantisof relevant clinicalinterest. Objectives: To analyzeHCMV-specificCD4+ and CD8+ T-cell responsesinhealthysubjectsandkidney transplant recipients(KTR). Study design: HCMV-specific T-cellresponseswereevaluatedbyinterferon- (IFN-) enzyme-linked immunospot (ELISPOT)usingoverlapping15-merpeptidepoolsofimmediateearly(IE)-1,IE-2,phos- phoprotein 65(pp65)(forstimulationofbothCD4+ and CD8+ T-cell responses)andapoolof34short peptides (8–12aminoacidsinlength,forstimulationofCD8+ T-cell responses).ELISPOTresultswere normalized toT-cellsubsetcountsandtheircorrelationswithareporteddendriticcell(DC)-basedassay, which simultaneouslyquantifiesHCMV-specificCD4+ and CD8+ T-cell responses,wereanalyzed. Results: HCMV-seropositive KTRshowedhigherELISPOTresponsescomparedtoHCMV-seropositive healthy subjects.IE-1andpp65ELISPOTresponsesweremediatedmainlybyCD8+ T-cells and,toa lesser extent,CD4+ T cells;IE-2peptidesappeartostimulateCD56+ cells (naturalkillercells).InHCMV- seropositive healthysubjects,ELISPOTresults(expressedeitherasnetspots/millioncellsornormalized to thecorrespondingT-cellcount)significantlycorrelatedwiththeDCassay.However,inHMCV- seropositive KTR,onlynormalizedELISPOTresponsestooverlapping15-merpeptidepoolssignificantly correlated withDC-assayresponses. Conclusions: The normalizedELISPOTrepresentsanovelandsimpleapproachforquantifyingandmoni- toring HCMV-specificCD4+ and CD8+ T-cell responsesinKTRFile | Dimensione | Formato | |
---|---|---|---|
Clinical virol 2014.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
860.29 kB
Formato
Adobe PDF
|
860.29 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.